[Financial News] RIGHT Fund announces new R&D projects for 2021
2021-07-27
The RIGHT Fund has announced 10 new R&D projects for 2021. One of them is the “Repeat Dose Toxicity Studies to Confirm the Safety of Novel TTCA Antitubercular Agent” project* conducted by the Medicinal Chemistry Team at Institut Pasteur Korea (IPK). The Medicinal Chemistry Team is using animal models to study the in vivo toxicity of anti-tuberculosis drug candidate, TTCA, identified through IPK’s image-based screening.